Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2
Yasuhiro Maejima1, Shiori Kyoi, Peiyong Zhai
11] Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA. [2] Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Abstract:
Here we show that Mst1, a proapoptotic kinase, impairs protein quality control mechanisms in the heart through inhibition of autophagy. Stress-induced activation of Mst1 in cardiomyocytes promoted accumulation of p62 and aggresome formation, accompanied by the disappearance of autophagosomes. Mst1 phosphorylated the Thr108 residue in the BH3 domain of Beclin1, which enhanced the interaction between Beclin1 and Bcl-2 and/or Bcl-xL, stabilized the Beclin1 homodimer, inhibited the phosphatidylinositide 3-kinase activity of the Atg14L-Beclin1-Vps34 complex and suppressed autophagy. Furthermore, Mst1-induced sequestration of Bcl-2 and Bcl-xL by Beclin1 allows Bax to become active, thereby stimulating apoptosis. Mst1 promoted cardiac dysfunction in mice subjected to myocardial infarction by inhibiting autophagy, associated with increased levels of Thr108-phosphorylated Beclin1. Moreover, dilated cardiomyopathy in humans was associated with increased levels of Thr108-phosphorylated Beclin1 and signs of autophagic suppression. These results suggest that Mst1 coordinately regulates autophagy and apoptosis by phosphorylating Beclin1 and consequently modulating a three-way interaction among Bcl-2 proteins, Beclin1 and Bax.
Insights
The proapoptotic kinase Mst1 inhibits autophagy, a key protein quality control process in the heart. This leads to cardiac dysfunction and dilated cardiomyopathy by disrupting the Beclin1-Bcl-2-Bax interaction.
Area of Science:
- Cardiovascular Biology
- Cellular Mechanisms
- Molecular Cardiology
Background:
- Protein quality control is crucial for cardiac function.
- Autophagy, a cellular degradation process, is vital for maintaining heart health.
- Dysregulation of autophagy is implicated in cardiac diseases.
Purpose of the Study:
- To investigate the role of Mst1 kinase in cardiac protein quality control.
- To elucidate the mechanism by which Mst1 affects autophagy in cardiomyocytes.
- To determine the link between Mst1, autophagy, and cardiac dysfunction.
Main Methods:
- Studied Mst1 activation in cardiomyocytes under stress.
- Analyzed p62, aggresome, and autophagosome levels.
- Investigated Mst1 phosphorylation of Beclin1 at Thr108.
- Assessed interactions between Beclin1, Bcl-2, Bcl-xL, and Bax.
- Examined cardiac function in Mst1-manipulated mice and human dilated cardiomyopathy patients.
Main Results:
- Mst1 activation inhibited autophagy and promoted aggresome formation.
- Mst1 phosphorylated Beclin1 at Thr108, enhancing Beclin1-Bcl-2/Bcl-xL interaction and inhibiting autophagy.
- Mst1-induced Beclin1 sequestration of Bcl-2/Bcl-xL activated Bax, promoting apoptosis.
- Mst1 inhibition of autophagy correlated with cardiac dysfunction in myocardial infarction mice.
- Increased Thr108-phosphorylated Beclin1 and suppressed autophagy were observed in human dilated cardiomyopathy.
Conclusions:
- Mst1 impairs cardiac protein quality control by inhibiting autophagy.
- Mst1 phosphorylation of Beclin1 at Thr108 is a key mechanism linking Mst1 to autophagy and apoptosis.
- Mst1 represents a potential therapeutic target for cardiac diseases associated with autophagic dysfunction.
More Related Videos
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
PI3K/mTOR/AKT Signaling Pathway


